Clinical Trial Update: Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study) [Phase 4]

View source ↗

Summary

Phase 4 study investigating personalized indicators to predict response to SSRI treatment in major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: University of California, Los Angeles | Conditions: Depression | Phase 4 | Status: COMPLETED